Regulation of N-cadherin-based cell–cell interaction by JSAP1 by Bayarsaikhan Munkhuu et al.
Regulation of N-cadherin-based cell cell
interaction by JSAP1
著者 Bayarsaikhan Munkhuu, Takino Takahisa,












Biochemical and Biophysical Research Communications xxx (2007) xxx–xxxRegulation of N-cadherin-based cell–cell interaction by JSAP1
scaﬀold in PC12h cells
Munkhuu Bayarsaikhan a, Takahisa Takino b, Davaakhuu Gantulga a,
Hiroshi Sato b, Takashi Ito c, Katsuji Yoshioka a,*
a Division of Molecular Cell Signaling, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa 920-0934, Japan
b Division of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa 920-0934, Japan
c Department of Computational Biology, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa 277-8561, Japan
Received 30 November 2006Abstract
We previously reported that the level of c-Jun NH2-terminal kinase (JNK)/stress-activated protein kinase-associated protein 1
(JSAP1), a scaﬀold protein for JNK signaling, increases dramatically during nerve growth factor (NGF)-induced diﬀerentiation of
PC12h cells. In the present study, we investigated the function of JSAP1 during PC12h cell diﬀerentiation by knocking down the level
of JSAP1. The depletion of JSAP1 caused NGF-treated PC12h cells to form aggregates and impaired their diﬀerentiation. The aggre-
gation was not observed in JSAP1-depleted cells that were untreated or treated with epidermal growth factor. Immunocytochemical stud-
ies indicated that N-cadherin, but not E-cadherin, was localized to sites of cell–cell contact in the aggregated cells. Furthermore, an
inhibitory anti-N-cadherin antibody completely blocked the aggregation. Taken together, these results suggest that JSAP1 regulates
cell–cell interactions in PC12h cells speciﬁcally in the NGF-induced signaling pathway, and does so by modulating N-cadherin.
 2006 Elsevier Inc. All rights reserved.
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Ks), including the extracellular signal-regulated kinase
(ERK), c-Jun NH2-terminal kinase (JNK), and p38 sub-
groups, are activated in response to a variety of extracellu-
lar and intracellular stimuli [1,2]. Mammalian MAPK
signaling pathways, in which MAPK is activated by a
phosphorylation relay, from MAPK kinase kinase to
MAPK kinase to MAPK, play pivotal roles in multiple cel-
lular processes, including proliferation, diﬀerentiation,
apoptosis, and migration [1–4]. Scaﬀold proteins of the
mammalian MAPK cascades are thought to function in
the spatio-temporal regulation of these pathways by orga-
nizing the MAPK signaling components into functional
modules [5,6]. The functional complexes enable the eﬃcient0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
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Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2006.12.029signal transduction of speciﬁc MAPK cascades. JNK/
stress-activated protein kinase-associated protein 1
(JSAP1, also known as JNK-interacting protein 3) was ini-
tially identiﬁed as a JNK-binding protein by our group and
others, and biochemical studies have suggested that JSAP1
functions as a scaﬀold protein for JNK MAPK cascades
[7–9]. Targeted gene-disruption studies in mice and an in vi-
tro diﬀerentiation study with jsap1-deﬁcient mouse ES cells
showed that JSAP1 is required for embryonic neurogenesis
[10–12].
The expression level of JSAP1 in rat pheochromocyto-
ma PC12 cells increases dramatically during their nerve
growth factor (NGF)-induced diﬀerentiation into neuron-
like cells [8,13]. However, the physiological function of
JSAP1 remains to be elucidated. In the present study, we
established PC12 cell lines expressing a short hairpin
RNA (shRNA) against JSAP1, in which JSAP1 expression
is severely decreased, and we used these JSAP1 knockdownof N-cadherin-based cell–cell interaction by JSAP1 ..., Biochem.
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ARTICLE IN PRESS(KD) cells to investigate the function of JSAP1. Our results
suggest that JSAP1 regulates cell–cell interactions in PC12
cells speciﬁcally in the NGF-induced signaling pathway, by
modulating N-cadherin.
Materials and methods
Cell culture and reagents. PC12h cells, a subclone of PC12 cells [14],
were cultured on collagen-coated dishes in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Sigma–Aldrich) containing 5% fetal bovine serum
(FBS) and 5% horse serum. For diﬀerentiation, PC12h cells were cultured
in DMEM containing 5% FBS and 5% horse serum at a density of 0.5 to
1 · 104 cells/cm2 overnight on collagen-coated dishes. The medium was
then changed to DMEM containing 50 ng/ml NGF (2.5S form, Alomone
Labs) and 1% horse serum. Madin-Darby canine kidney (MDCK) and
human embryo kidney (HEK) 293T cells were cultured in DMEM con-
taining 10% FBS. Type I collagen and Hoechst 33258 were purchased
from Wako Pure Chemical Industries and Nacalai Tesque, respectively.
Epidermal growth factor (EGF), puromycin, and Sequa-brene were from
Sigma–Aldrich.
Antibodies. Monoclonal antibodies against E-cadherin, N-cadherin, b-
catenin, and p120-catenin were purchased from BD Biosciences. An
aﬃnity-puriﬁed anti-JSAP1 polyclonal antibody was described previously
[15,16]. A rabbit anti-JNK-associated leucine zipper protein (JLP) anti-
body was raised against a peptide (CTLSQLPGDKSKAFDF) corre-
sponding to amino acid residues 581–595 of mouse JLP (GenBank
Accession No. AF327451), and was aﬃnity puriﬁed using the peptide. The
anti-actin polyclonal antibody and anti-N-cadherin monoclonal antibody,
which reacts with the N-terminal half of the extracellular domain of
N-cadherin and inhibits adherens junction formation, were obtained from
Sigma–Aldrich. The anti-JNK polyclonal antibody and anti-phospho-
speciﬁc JNK monoclonal antibody were from Cell Signaling.
Plasmid construction. The retroviral vector pMKO.1-puro [17] was
kindly provided by Dr. W.C. Hahn (Dana-Farber Cancer Institute,
Harvard Medical School). The human U6 promoter in the pMKO.1-puro
was replaced with the mouse U6 promoter by introducing a 0.3-kb
BamHI–AgeI fragment containing the mouse U6 promoter, which was
obtained by PCR using the vector pBAsi-mU6 (TaKaRa), into BglII/
AgeI-digested pMKO.1-puro, to generate pmMKO.1-puro. The following
phosphorylated and annealed small interfering RNA oligos with hairpin
sequences targeted against JSAP1 were inserted into the AgeI and EcoRI
sites of pmMKO.1-puro: JSAP1-shRNA1, forward, 50-CCGGCAGT
GTCACAAAGAACAACAACTCGAGTTGTTGTTCTTTGTGACACT
GTTTTTG-30 and reverse, 5 0-AATTCAAAAA CAGT GTCACAAAG
AACAACAATTGTTGTTCTTTGTGACACTG-3 0; JSAP1-shRNA2,
forward, CCGGCCGAATCAAAGAGCTTGAAGCCTCGAGTCTTC
AAGCTCTTTGATTCGGTTTTTG-30 and reverse, 5 0-AATTCAAAA
ACCGAATCAAAGAGCTTGAAGACTCGAGTCTTCAAGCTCTTT
GATTCGG-3 0; JSAP1-shRNA3, forward, 5 0-CCG GCTCAC AGAGC
ATGTCTTTACTCTCGAGAGTAAAGACATGCTCTGTGAGTTTT
TG-3 0 and reverse, 5 0-AATTCAAAAACTCACAGAGCATGTCTTT
ACTCTCGAGAGTAAAGACATGCTCTGTGAG-3 0; JSAP1-shRNA4,
forward, 5 0-CCGGCGGTAGCCAACTGGAAGAAGTCTCGAGAC
TTCTTCCAGTTGGCTACCGTTTTTG-30 and reverse, 5 0-AATTCA
AAAACGGTAGCCAACTGGAAGAAGTCTCGAGACTTCTTCCA
GTTGGCTACCG-30, where the underlined letters represent mouse
JSAP1 sequences (GenBank Accession No. AB005662). The resultant
vectors were named pmMKO.1-puro-JSAP1-shRNA1-4.
Western blotting. Cultured cells were lysed in the following buﬀer:
50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 10% glycerol,
1% SDS, and protease inhibitor cocktail (Sigma–Aldrich). The extracts
were spun for 10 min at 12,000g at 4 C, and the supernatants were used as
the protein samples. Western blot analysis was carried out as described
previously [13].
Virus production and screening of cell lines stably expressing JSAP1
shRNA. HEK 293T cells were plated on 60-mm dishes at a density of
2 · 106 cells/dish. After 24 h, the cells were co-transfected with 1 lg ofPlease cite this article in press as: M. Bayarsaikhan et al., Regulation
Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2006.12.029empty pmMKO.1-puro, pmMKO.1-puro-JSAP1-shRNA1, -shRNA2,
-shRNA3, or -shRNA4 and 1 lg of pCL-Ampho (Imgenex), a vector
encoding a replication-defective helper virus, using FuGENE 6 (Roche
Diagnostics). Forty-eight hours after transfection, the supernatants, con-
taining amphotropic retroviruses, were collected, passed through a ﬁlter
(0.45 lm), supplemented with Sequa-brene (ﬁnal concentration, 8 lg/ml),
and used for infection. PC12h cells were plated on collagen-coated dishes
(1 · 106 cells/35-mm dish). After 24 h, the cells were infected with the
amphotropic retroviruses, and another 24 h later, selection of the infected
cells was started in medium containing 500 ng/ml puromycin. The selected
cell populations were subjected to Western blotting with an anti-JSAP1
antibody to examine the silencing eﬃciency of the JSAP1-shRNAs. To
obtain clones expressing JSAP1-shRNA1, PC12h cells plated on collagen-
coated dishes (1 · 106 cells/35-mm dish) were infected with serially diluted
recombinant retrovirus for JSAP1-shRNA1, and the cells were selected as
described above. The expression of JSAP1 protein in independent clones
was examined by Western blotting using the anti-JSAP1 antibody.
Time-lapse video microscopy. Cell movements were monitored using an
Olympus inverted microscope as described previously [18]. Video images
were collected at one-hour intervals for 48 h, and the image stacks were
converted to QuickTime movies.
Immunoﬂuorescence. PC12h cells were washed once with phosphate-
buﬀered-saline (PBS) and ﬁxed in 4% paraformaldehyde for 15 min. They
were then permeabilized by incubation in PBS containing 0.1% Triton
X-100 for 20 min on ice, blocked in PBS containing 0.1% Tween 20
(PBST) and 3% bovine serum albumin for 1 h at room temperature, and
then incubated overnight at 4 C with primary antibodies. After being
washed with PBST, the cells were incubated for 1 h with an Alexa 546-
conjugated secondary antibody (Molecular Probes). The stained cells were
then examined by ﬂuorescence microscopy.Results
Screening for an eﬀective shRNA against JSAP1 and
establishment of stable PC12h cell lines expressing the
shRNA
To investigate the physiological functions of JSAP1, we
used the RNA interference (RNAi) approach. We exam-
ined the eﬀectiveness of four JSAP1-shRNAs: JSAP1-
shRNA1, -shRNA2, -shRNA3, and -shRNA4 (see Materi-
als and methods). To this end, PC12h cells were infected
with the respective recombinant retroviruses for these
JSAP1-shRNAs, selected in the presence of puromycin,
and analyzed by Western blotting. The expression level of
JSAP1 protein in the JSAP1-shRNA4-expressing cells
was comparable to that in the wild-type parent PC12h cells
and in control PC12h (PC12hctrl) cells that had been infect-
ed with empty retrovirus (Fig. 1A; compare lanes 1, 2, and
6). The other three JSAP1-shRNAs decreased the JSAP1
expression in PC12h cells, with the most eﬀective shRNA
being JSAP1-shRNA1 (Fig. 1A). None of these JSAP1-
shRNAs decreased the level of JLP, a highly related family
member of JSAP1 [19] (Fig. 1A). In PC12h cells treated
with NGF for 5 days, JSAP1-shRNA1 reduced the JSAP1
expression by 70–80% (Fig. 1B). Because the puromycin-re-
sistant cells infected with the JSAP1-shRNA1 expression
retrovirus could be heterogeneous with respect to JSAP1
expression, and furthermore, because cells expressing
somewhat low or even quite low levels of JSAP1 protein
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Fig. 1. Establishment of stable PC12h cell lines expressing shRNA against
JSAP1. (A) PC12h cells were infected independently with recombinant
retroviruses for JSAP1-shRNA1, -shRNA2, -shRNA3, and -shRNA4,
and selected in the presence of puromycin. Cells were cultured without
NGF. Total cell lysates were prepared from the respective pooled cells,
and subjected to Western blotting with antibodies against JSAP1 and JLP,
a JSAP1 family member. The wild-type (wt) parent PC12h cells, and the
control (ctrl) PC12h cells, which were infected with empty retrovirus, were
used as controls. (B) The control PC12h cells and the pooled PC12h cells
stably expressing JSAP1-shRNA1 were treated with NGF (50 ng/ml) for
the indicated periods: 1d, 1 day; 3d, 3 days; 5d, 5 days. JSAP1 protein
expression was analyzed as in (A). (C) The control PC12h cells and the
JSAP1 KD cells of clones #9, #12, and #22, which were obtained after
screening the pooled cells infected with JSAP1-shRNA1-expressing
retrovirus, were cultured for 5 days in the presence of NGF (50 ng/ml),
and subjected to Western blotting as in (A). The expression of actin is
shown as a loading control. The positions of protein size markers are
indicated on the left.
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JSAP1 protein. Indeed, the expression level of JSAP1 pro-
tein was diﬀerent among distinct clones (data not shown),
and almost no expression of JSAP1 protein was observed
in clones #9, #12, and #22 after 5 days of NGF treatment
(Fig. 1C).JSAP1 KD PC12h cells form aggregates in response to NGF
The PC12hctrl cells and the JSAP1 KD cells of clones #9,
#12, and #22 were cultured in the presence of NGF for 3Please cite this article in press as: M. Bayarsaikhan et al., Regulation
Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2006.12.029days, and then examined for morphological diﬀerences.
Most of the PC12hctrl cells extended neurites during the
process of NGF-induced diﬀerentiation (Fig. 2A(b)), con-
sistent with our previous observations [13]. In contrast,
the depletion of JSAP1 caused NGF-treated PC12h cells
to form aggregates and impaired their diﬀerentiation. In
the aggregates, some of the peripheral cells possessed neu-
rites, but the remaining peripheral cells and the cells inside
the aggregates did not (Fig. 2A(d, f, and h)). The average
number of cells per cell unit, where either a single cell or
a cell cluster of two or more cells was considered one cell
unit, was 1.6 for the PC12hctrl cells, and 7.2, 5.4, and 4.5
for clones #9, #12, and #22, respectively (Fig. 2B). The
corresponding number in the pooled PC12h cell population
expressing JSAP1-shRNA1 was 2.8, which was smaller
than the numbers obtained for the JSAP1 KD clones, as
expected (Fig. 2B). Note that in the PC12hctrl cells, the
average cell number per cell unit decreased after treatment
with NGF (Fig. 2B). Whether cultured with EGF or with-
out a growth factor, the cells of the JSAP1 KD clones
showed no apparent diﬀerence in aggregation from the
PC12hctrl cells (Fig. 2A, left panels; data not shown).
Indeed, the average cell numbers per cell unit were similar
among the PC12hctrl cells and JSAP1 KD clones in the
absence of NGF (Fig. 2B). These observations indicate that
the phenomenon of cell–cell aggregation occurs speciﬁcally
as a result of NGF-induced signaling in PC12h cells. To
clarify the molecular mechanism underlying the formation
of JSAP1 KD cellular aggregates, we performed further
experiments using clones #9 and #22, with the PC12hctrl
cells as a control.
JSAP1 KD causes cell aggregation by promoting N-
cadherin-mediated cell–cell adhesion in NGF-treated PC12h
cells
We ﬁrst examined cell behaviors, focusing on cell–cell
association and dissociation, by time-lapse video microsco-
py. After NGF treatment, video images were collected for
48 h at one-hour intervals, and the images were converted
into movies. The PC12hctrl cells seemed to undergo active
cell–cell dissociation and very weak cell–cell association,
whereas the opposite cell behaviors were exhibited by the
JSAP1 KD cells (Fig. 3A). These results suggested that a
cell–cell adhesion molecule(s) might be involved in the for-
mation of the aggregates. To examine this possibility, we
performed immunostaining for the classical cadherins, the
E- and N-cadherins. As shown in Fig. 3B, N-cadherin,
but not E-cadherin, was detected at almost all the sites of
cell–cell contact in the JSAP1 KD cellular aggregates. We
conﬁrmed the ability of the anti-E-cadherin antibody to
detect its protein at cell–cell contacts using the MDCK epi-
thelial cell line (data not shown). We next asked whether
N-cadherin is the major molecule promoting cell–cell adhe-
sion in the aggregates. When cultured in the presence of an
inhibitory antibody for N-cadherin, no aggregates were


























Fig. 2. NGF-induced cell–cell aggregation in JSAP1 KD PC12h cells. (A)
The control (ctrl) PC12h cells (a,b), JSAP1 KD cells from clones #9 (c,d),
#12 (e,f), and #22 (g,h), and pooled cells (i,j) expressing JSAP1-shRNA1
were cultured on collagen-coated dishes for 3 days in the presence or
absence of NGF (50 ng/ml), and stained with Hoechst 33258. Scale bar,
100 lm. (B) To quantify the results of (A), the average number of cells per
cell unit, which consisted of a single cell or a cluster of two or more cells,
was determined. Over 100 cells were examined in each case. Values are the
means ± SEM from three independent experiments.
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ARTICLE IN PRESSinhibitory antibody, however, did not aﬀect the cell–cell
adhesion of the MDCK cells under similar culture condi-
tions (data not shown). We also analyzed the expressionPlease cite this article in press as: M. Bayarsaikhan et al., Regulation
Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2006.12.029levels of the E- and N-cadherins, and their related proteins,
b-catenin and p120-catenin, by Western blotting, using
cells harvested 0, 1, 3, and 5 days after NGF treatment.
The expression levels of the E- and N-cadherins increased
slightly in the JSAP1 KD cells compared with the PC12hctrl
cells, in response to NGF stimulation (Fig. 3D), and there
were no signiﬁcant diﬀerences in the levels of b-catenin and
p120-catenin between the PC12hctrl cells and JSAP1 KD
clones #9 and #22 (data not shown). Taken together, these
results suggested that during NGF-induced signaling in
PC12h cells, JSAP1 regulates the expression of N-cadherin,
and that the depletion of JSAP1 disrupts the normal regu-
lation of N-cadherin-based cell–cell adhesion, leading to
the formation of cellular aggregates.
Immunoblotting analysis of JNK in the NGF-treated control
and JSAP1 KD PC12h cells
Because JSAP1 has been identiﬁed as a scaﬀold protein
for JNK signaling [7,8], we asked whether the depletion of
JSAP1 aﬀects the activation of JNK during NGF-induced
signaling in PC12h cells. For this purpose, we examined the
expression of the phosphorylated, activated form of JNK
by Western blotting, using cells harvested 0, 1, 3, and 5
days after NGF treatment (Fig. 4). The total JNK levels
were similar between the PC12hctrl and the JSAP1 KD cells
of clones #9 and #22, and the level of phosphorylated and
activated JNK increased greatly in the PC12hctrl cells on
days 3 and 5; activated JNK levels also increased, but to
a lesser degree, in the JSAP1 KD cells.
Discussion
Cell–cell interactions and other cellular processes, such
as cell proliferation, diﬀerentiation, apoptosis, and migra-
tion, are coordinately regulated in multicellular organisms
during development and the subsequent maintenance of
homeostasis. Here we investigated the function of JSAP1,
a scaﬀold protein for JNK MAPK cascades, during
NGF-induced diﬀerentiation, using the rat pheochromocy-
toma cell line PC12h as a model system. We ﬁrst estab-
lished stable cell lines expressing an shRNA against
JSAP1, in which there was almost no expression of JSAP1
protein (Fig. 1C), and found that the depletion of JSAP1
caused NGF-treated PC12h cells to aggregate and
impaired their diﬀerentiation (Fig. 2). These phenomena
were not observed in JSAP1 KD cells that were untreated
or treated with EGF, indicating that the depletion of
JSAP1 causes these defects in PC12h cells speciﬁcally dur-
ing NGF-induced signaling.
Immunostaining analysis showed the presence of N-cad-
herin, but not E-cadherin, at the cell–cell contact sites of
the aggregated JSAP1-depleted cells (Fig. 3B). Further-
more, an anti-N-cadherin antibody that reacts with the
extracellular domain of N-cadherin and is known to inhibit
adherens junction formation, completely blocked the
























Fig. 3. N-cadherin-mediated cell–cell adhesion in NGF-treated JSAP1 KD cells. (A) The control (ctrl) PC12h cells and the JSAP1 KD cells from clones
#9 and #22 were cultured on collagen-coated dishes and monitored by time-lapse video microscopy at one-hour intervals for 48 h, in medium containing
NGF (50 ng/ml). Representative video images of the control cells and the JSAP1 KD cells from clones #9 and #22 are shown. Numbers represent the time
in hours after the addition of NGF. Scale bar, 25 lm. (B) The control (ctrl) PC12h cells and the JSAP1 KD cells of clones #9 and #22 were cultured on
collagen-coated dishes for 3 days in the presence of NGF (50 ng/ml). The cells were then ﬁxed and immunostained for E- and N-cadherin. Scale bar,
50 lm. (C) The JSAP1 KD cells of clones #9 and #22 were cultured on collagen-coated dishes for 3 days in the presence of NGF (50 ng/ml) with or
without an inhibitory antibody for N-cadherin. The ﬁnal concentration of the inhibitory anti-N-cadherin antibody was 300 lg/ml. The cells were then
stained with Hoechst 33258. Scale bar, 100 lm. (D) Control (ctrl) PC12h cells and JSAP1 KD cells from clones #9 and #22 were cultured on collagen-
coated dishes for 1–5 days in the presence of NGF (50 ng/ml), as indicated: 1d, 1 day; 3d, 3 days; 5d, 5 days. Total cell lysates were prepared, and analyzed
by Western blotting with anti-N-cadherin or anti-E-cadherin antibodies (upper two panels). Actin expression is shown as a loading control (bottom panel).
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Fig. 4. Activation of JNK and expression of JSAP1 during NGF-induced
signaling in the control and JSAP1 KD PC12h cells. The control (ctrl)
PC12h cells and the JSAP1 KD cells from clones #9 and #22 were
cultured on collagen-coated dishes for 1–5 days in the presence of NGF
(50 ng/ml), as indicated: 1d, 1 day; 3d, 3 days; 5d, 5 days. Total cell lysates
were then prepared and analyzed by Western blotting with anti-phospho-
JNK (P-JNK), anti-JNK, and anti-JSAP1 antibodies (upper three panels).
Arrowheads indicate the positions of phosphorylated JNKs. The expres-
sion of actin is shown as a loading control (bottom panel). The positions
of protein size markers are indicated on the left.
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Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2006.12.029N-cadherin increased slightly in the JSAP1 KD cells com-
pared with the PC12hctrl cells, in response to NGF stimula-
tion, (Fig. 3D). These results strongly suggest that the key
binding molecule at the cell–cell junctions is N-cadherin,
and that JSAP1 regulates the cell–cell interaction in
NGF-induced PC12h cells by modulating N-cadherin
expression. Chen et al. [20] reported that the overexpres-
sion of modiﬁer of cell adhesion [MOCA; also known as
dedicator of cytokinesis 3 (DOCK3)] in HEK293T and
PC12 cells, among others, promoted N-cadherin-mediated
cell–cell adhesion in association with increased N-cadherin
expression. This phenotype is similar to that observed in
our JSAP1 KD cells. Thus, JSAP1 might regulate the
expression of N-cadherin by modulating the expression of
MOCA and/or other proteins with a similar function.
However, we cannot rule out the possibility that JSAP1
modulates a diﬀerent aspect of N-cadherin function. It is
possible that JSAP1 regulates the subcellular localization
of N-cadherin, which is a transmembrane protein, by mod-
ulating the traﬃcking of N-cadherin to and/or from the cellof N-cadherin-based cell–cell interaction by JSAP1 ..., Biochem.
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ARTICLE IN PRESSsurface by exocytic and/or endocytic pathways. The altered
subcellular localization of N-cadherin in the JSAP1 KD
PC12h cells might interfere with cell–cell dissociation and
enhance cell–cell association, which together could pro-
mote cell aggregation.
In the present study, we demonstrated that the scaﬀold
protein JSAP1 regulates cell–cell interaction in the NGF-in-
duced signaling in PC12h cells. Since JSAP1 and the JNKs,
especially JNK3, are highly expressed in the developing ner-
vous system [10–12,15,21], and since JNK cascades are
known to be required for many cellular processes, including
apoptosis, diﬀerentiation, and cell migration [1–4,22], our
ﬁnding raises the intriguing possibility that the scaﬀold pro-
tein JSAP1may be involved in the coordinated regulation of
cell–cell interaction and the other multiple cellular processes
in the developing nervous system, by modulating JNK sig-
naling pathways spatially and temporally.
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